Viral Vector Biosafety in Laboratory Animal Research.

Comp Med 2017 Jun;67(3):215-221

University of Michigan, Ann Arbor, Michigan;, Email:

Viral vector research presents unique occupational health and safety challenges to institutions due to the rapid development of both in vivo and in vitro gene-editing technologies. Risks to human and animal health make it incumbent on institutions to appropriately evaluate viral vector usage in research on the basis of available information and governmental regulations and guidelines. Here we review the factors related to risk assessment regarding viral vector usage in animals and the relevant regulatory documents associated with this research, and we highlight the most commonly used viral vectors in research today. This review is particularly focused on the background, use in research and associated health and environmental risks related to adenoviral, adeno-associated viral, lentiviral, and herpesviral vectors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482513PMC
June 2017
Get 20% Off Journals at LWW.com

Similar Publications

Detection of Myxoma Virus DNA in Ticks from Lagomorph Species in Spain Suggests Their Possible Role as Competent Vector in Viral Transmission.

J Wildl Dis 2021 Feb 24. Epub 2021 Feb 24.

Myxoma virus (MYXV) causes morbidity and mortality in European wild rabbits (Oryctolagus cuniculus) worldwide, and recently in Iberian hares (Lepus granatensis) in Spain. We aimed to assess the presence of MYXV-specific DNA in ixodid ticks collected from both hosts. A total of 417 ticks harvested from 30 wild lagomorphs, including wild rabbits and Iberian hares were collected from southern Spain. Read More

View Article and Full-Text PDF
February 2021

Monoclonal Antibody That Inhibits Cleavage Activity of Japanese Encephalitis Virus NS3.

Monoclon Antib Immunodiagn Immunother 2021 Feb;40(1):28-32

Hubei Engineering Research Center of Viral Vector, Applied Biotechnology Research Center, Wuhan University of Bioengineering, Wuhan, China.

Flavivirus protease has been deemed a potential target for drug and therapeutics development due to its crucial role in viral replication. In this study we prepared a monoclonal antibody (mAb) against nonstructural protein 3 (NS3) protease portion of Japanese encephalitis virus (JEV), and evaluated its inhibitory effect for NS3 protease activity. First, a JEV NS3 protease-specific mAb (designated 2C2) was generated by the traditional cell fusion technique. Read More

View Article and Full-Text PDF
February 2021

Advances in cell and gene therapy for HIV disease: it is good to be specific.

Curr Opin HIV AIDS 2021 Mar;16(2):83-87

Washington Health Institute and George Washington School of Medicine, Washington, DC, USA.

Purpose Of Review: Tremendous advances in cell and gene therapy may soon realize the goal of treating and possibly curing HIV disease. These advances rely on new technologies for cell engineering and new strategies for product manufacturing that are targeting the most important immune deficits in HIV and promising to reconstitute protective, antiviral immunity and achieve natural suppression of HIV disease.

Recent Findings: We summarize important advances in vectored passive immunity, e. Read More

View Article and Full-Text PDF

Thermo Fisher Adds Capacity with Purchase of Novasep's Viral Vector Business.

Authors:
Alex Philippidis

Hum Gene Ther 2021 Feb;32(3-4):133-135

Mary Ann Liebert, Inc., Publishers, New Rochelle, New York, USA.

View Article and Full-Text PDF
February 2021

Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus.

Nat Commun 2021 02 22;12(1):1203. Epub 2021 Feb 22.

School of Biological Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE, USA.

Influenza A virus infection in swine impacts the agricultural industry in addition to its zoonotic potential. Here, we utilize epigraph, a computational algorithm, to design a universal swine H3 influenza vaccine. The epigraph hemagglutinin proteins are delivered using an Adenovirus type 5 vector and are compared to a wild type hemagglutinin and the commercial inactivated vaccine, FluSure. Read More

View Article and Full-Text PDF
February 2021